Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.28

+5.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Scott H. Davis who wrote (2420)	12/29/2000 5:03:54 PM
From: scaram(o)uche	Read Replies (2) of 52153

Q. On this chart, how much money did IDPH have, 1/95? quote.yahoo.com A. None. Q. On this chart, how much money did IMGN have, 12/97? quote.yahoo.com A. None, or next to it. Despite the nonsense dogma that was spewed by the underwriters (and their folly followers), 3/2000, returns are traditionally best in big-science companies that are almost broke. The "how to invest in biotech" lists are most often trumpeted by those who would take your money. Their PAs are loaded with cash-strapped small caps. Biotech is a sector, like none other, where leverage can be your friend. If you go looking for cash-rich companies, you will rob yourself of many (most, IMO) big ops. Even in the "depth of despair" years..... the 1997 success story..... AGPH had to dip way down to $30 or so for a dilutive offering. Hurt like hell. For just awhile. :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next